{"id":4520,"date":"2016-01-08T00:10:14","date_gmt":"2016-01-08T05:10:14","guid":{"rendered":"http:\/\/sciencemediacentre.ca\/site\/?p=4520"},"modified":"2016-02-26T11:12:35","modified_gmt":"2016-02-26T16:12:35","slug":"biologics-and-biosimilars-smcc-webinar","status":"publish","type":"post","link":"http:\/\/sciencemediacentre.ca\/site\/biologics-and-biosimilars-smcc-webinar\/","title":{"rendered":"Biologics and Biosimilars | SMCC Webinar"},"content":{"rendered":"<p><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-full wp-image-118 aligncenter\" src=\"http:\/\/sciencemediacentre.ca\/site\/wp-content\/uploads\/2013\/12\/SMCC-english4.jpg\" alt=\"SMCC-english4\" width=\"150\" height=\"82\" \/><\/p>\n<h4 style=\"text-align: center;\"><b><strong>Biologics and\u00a0Biosimilars\u00a0<\/strong>\u00a0| SMCC Webinar | January 7, 2016 | Video available<\/b><\/h4>\n<p>Biopharmaceuticals, or Biologics have successfully improved the care of several hard to treat conditions, such as\u00a0rheumatoid arthritis,\u00a0Crohn&#8217;s disease and cancer. More of these complex biological drugs are coming. In the US over 900 biologics are being developed for more than 100 diseases. While they can be effective treatments,\u00a0they can be very expensive and are the largest driver of drug spending in Canada. This year, and over the next few years, a wave of biologic drugs will lose their patents, opening the door for less expensive &#8220;biosimilars&#8221; or Subsequent Entry Biologics (SEBs).<\/p>\n<p>&nbsp;<\/p>\n<h3>A video of the webinar presentation is available below.<\/h3>\n<p>&nbsp;<\/p>\n<p>On January 7, 2016 the SMCC hosted a webinar, which will\u00a0provide answers to questions about Biologics and SEBs, including:<\/p>\n<ul>\n<ul>\n<li>What are biosimilars or SEBs and how do they differ from generic drugs?<\/li>\n<li>What do patients need to know?<\/li>\n<li>What are the cost implications of SEBs to Canada&#8217;s health care system and to patients?<\/li>\n<li>What are the scientific and regulatory issues to consider?<\/li>\n<\/ul>\n<\/ul>\n<p>Speakers included:<\/p>\n<p><span style=\"text-decoration: underline;\"><a href=\"http:\/\/spph.ubc.ca\/person\/steve-morgan\/\">Prof. Steve Morgan<\/a><\/span>,\u00a0<em>Faculty of Medicine, School of Population and Public Health, University of British Columbia<\/em><\/p>\n<p><span style=\"text-decoration: underline;\"><a href=\"https:\/\/www.utm.utoronto.ca\/mbiotech\/faculty-staff\/revers-leigh\">Dr. Leigh Revers<\/a><\/span>,\u00a0<em>Associate Director and Senior Lecturer, Master of Biotechnology Program, University of Toronto<\/em><\/p>\n<p><span style=\"text-decoration: underline;\"><a href=\"http:\/\/www.bcrenalagency.ca\/dan-martinusen\">Dr. Dan Martinusen<\/a><\/span><em>,Vancouver Island Health Authority renal pharmacist and chair of the BC Renal Agency\u2019s Pharmacy and Formulary Committee<\/em><\/p>\n<p>&nbsp;<\/p>\n<div style=\"width: 854px;\" class=\"wp-video\"><video class=\"wp-video-shortcode\" id=\"video-4520-1\" width=\"854\" height=\"480\" preload=\"metadata\" controls=\"controls\"><source type=\"video\/mp4\" src=\"http:\/\/sciencemediacentre.ca\/site\/wp-content\/uploads\/2016\/01\/biologics_vff.mp4?_=1\" \/><a href=\"http:\/\/sciencemediacentre.ca\/site\/wp-content\/uploads\/2016\/01\/biologics_vff.mp4\">http:\/\/sciencemediacentre.ca\/site\/wp-content\/uploads\/2016\/01\/biologics_vff.mp4<\/a><\/video><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Biologics and\u00a0Biosimilars\u00a0\u00a0| SMCC Webinar | January 7, 2016 | Video available Biopharmaceuticals, or Biologics have successfully improved the care of several hard to treat conditions, such as\u00a0rheumatoid arthritis,\u00a0Crohn&#8217;s disease and cancer. More of these complex biological drugs are coming. In the US over 900 biologics are being developed for more than 100 diseases. While they [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":false,"_jetpack_newsletter_tier_id":0,"_jetpack_memberships_contains_paywalled_content":false,"_jetpack_memberships_contains_paid_content":false,"footnotes":""},"categories":[168],"tags":[125,49,2484,2134,51,2478,53,50,476,2465],"class_list":["post-4520","post","type-post","status-publish","format-standard","hentry","category-webinar","tag-british-columbia","tag-cancer","tag-chrons","tag-disease","tag-health","tag-health-policy","tag-medicine","tag-ontario","tag-public-health","tag-research"],"jetpack_featured_media_url":"","jetpack_shortlink":"https:\/\/wp.me\/p4DqbN-1aU","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"http:\/\/sciencemediacentre.ca\/site\/wp-json\/wp\/v2\/posts\/4520","targetHints":{"allow":["GET"]}}],"collection":[{"href":"http:\/\/sciencemediacentre.ca\/site\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"http:\/\/sciencemediacentre.ca\/site\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"http:\/\/sciencemediacentre.ca\/site\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"http:\/\/sciencemediacentre.ca\/site\/wp-json\/wp\/v2\/comments?post=4520"}],"version-history":[{"count":8,"href":"http:\/\/sciencemediacentre.ca\/site\/wp-json\/wp\/v2\/posts\/4520\/revisions"}],"predecessor-version":[{"id":4618,"href":"http:\/\/sciencemediacentre.ca\/site\/wp-json\/wp\/v2\/posts\/4520\/revisions\/4618"}],"wp:attachment":[{"href":"http:\/\/sciencemediacentre.ca\/site\/wp-json\/wp\/v2\/media?parent=4520"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"http:\/\/sciencemediacentre.ca\/site\/wp-json\/wp\/v2\/categories?post=4520"},{"taxonomy":"post_tag","embeddable":true,"href":"http:\/\/sciencemediacentre.ca\/site\/wp-json\/wp\/v2\/tags?post=4520"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}